Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Off-Label Use”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Not applicableLooking for participantsNCT06967831
What this trial is testing

Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells

Who this might be right for
Leigh Syndrome (Maternally Inherited, MILS)Leigh Syndrome (AR, AD, XR)
Charite University, Berlin, Germany 80
Not applicableWithdrawnNCT05307627
What this trial is testing

The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging

Who this might be right for
Aging
AgelessRx
Not applicableStudy completedNCT00960713
What this trial is testing

The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders

Who this might be right for
PemphigusAuto-immune Thrombocytopenic PurpuraHemolytic Auto-immune Anaemia+2 more
University Hospital, Toulouse 35
Early research (Phase 1)Study completedNCT04090684
What this trial is testing

Ciprofloxacin/Celecoxib Combination in Patients With ALS

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
NeuroSense Therapeutics Ltd. 10
Not applicableLooking for participantsNCT07343024
What this trial is testing

Methods of Identifying Effective Off-Guideline Treatments for Advanced Cancer Patients (CC N-of-1)

Who this might be right for
Advanced Cancer
Cancer Commons 300
Post-approval studies (Phase 4)Ended earlyNCT03726996
What this trial is testing

Desipramine in Infantile Neuroaxonal Dystrophy (INAD).

Who this might be right for
Infantile Neuroaxonal Dystrophy
Duke University 4
Testing effectiveness (Phase 2)Study completedNCT04354870
What this trial is testing

COVID-19 PrEP HCW HCQ Study

Who this might be right for
COVID-19
NYU Langone Health 130
Testing effectiveness (Phase 2)WithdrawnNCT05726682
What this trial is testing

Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Allogenic Stem Cell Transplantation
Sanofi
Not applicableLooking for participantsNCT01286519
What this trial is testing

Pharmacokinetics of Off Label Pediatric Medications

Who this might be right for
Off Label Use of Medications in Pediatric Patients
University of North Carolina, Chapel Hill 400
Not applicableStudy completedNCT00633945
What this trial is testing

Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
University of Pennsylvania 5
Not applicableUnknownNCT05647980
What this trial is testing

Transmural Collaborative Care Model for CVRM and Medication Review for Patients Using Antipsychotics

Who this might be right for
Mental Disorders, Severe
Radboud University Medical Center 480
Not applicableNot Yet RecruitingNCT07738601
What this trial is testing

Patient Reported Outcome Measurement Within the Secured Access to Innovative Medicines for Children With cAncer (SACHA) Study

Who this might be right for
CNS Tumor, Childhood
Assistance Publique Hopitaux De Marseille 72
Large-scale testing (Phase 3)Study completedNCT00259272
What this trial is testing

Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine

Who this might be right for
Bipolar Disorder I or II
Eli Lilly and Company 141
Testing effectiveness (Phase 2)UnknownNCT04185831
What this trial is testing

A MolEcularly Guided Anti-Cancer Drug Off-Label Trial

Who this might be right for
Solid Tumor
Uppsala University Hospital 167
Not applicableStudy completedNCT01347619
What this trial is testing

IADAPT: Off Label Use of Antipsychotics in the Nursing Home

Who this might be right for
Off-label Use of Atypical Antipsychotic Drugs
University of Massachusetts, Worcester 42
Not applicableStudy completedNCT02240654
What this trial is testing

Evaluation of Potential Off-label Use of Dabigatran Etexilate in Europe

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 36,573
Large-scale testing (Phase 3)Study completedNCT04347031
What this trial is testing

The Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19

Who this might be right for
Pneumonia, ViralRespiratory Failure
Burnasyan Federal Medical Biophysical Center 320
Testing effectiveness (Phase 2)Ended earlyNCT04435808
What this trial is testing

Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19

Who this might be right for
COVID-19
University of New Mexico 1
Not applicableLooking for participantsNCT07215988
What this trial is testing

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

Who this might be right for
Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8+5 more
Ohio State University Comprehensive Cancer Center 70
Not applicableStudy completedNCT02954679
What this trial is testing

French Study on COgnitive Enhancement and Consumption of Psychoactive Substances Among Youth Students

Who this might be right for
Psychoactive Substances ConsumptionSubstance-related DisorderOff Label-use+1 more
Assistance Publique - Hôpitaux de Paris 30,000
Next Page